Screener
NewAmsterdam Pharma Company NAMS Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from NewAmsterdam Pharma Company’s reported figures.
Based on the most recent quarter.
The source filing: NewAmsterdam Pharma Company’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333824
FAQ
- What is NewAmsterdam Pharma Company's price / sales?
- NewAmsterdam Pharma Company (NAMS) reported price / sales of 556.4× in Q2 2026.
- How has NewAmsterdam Pharma Company's price / sales changed year-over-year?
- NewAmsterdam Pharma Company's price / sales increased by 1623.8% year-over-year, from 32.3× to 556.4×.
- What is the long-term trend for NewAmsterdam Pharma Company's price / sales?
- Over 3 years (2022 to 2025), NewAmsterdam Pharma Company's price / sales has grown at a 164.5% compound annual growth rate (CAGR), from 9.6× to 176.8×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about NewAmsterdam Pharma Company's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude